Community Clinical Oncology Program
Research Base Protocol Credit Assignment
Approved, Active, and Closed Protocols

Research Base North Central Cancer Treatment Group (NCCTG)
qry_Credit_Report_Output_HTML_NCCTG
Protocol Number Type of Cancer or Study Intergroup Number Coordinating Center Study Status Closure Date Treatment Credit Cancer Control Credit Followup Credit Followup Years Credit Description
95-92-55 Intervention Study

Closed 12/31/1999 0 0.5


95-92-57 Intervention Study

Closed 12/18/2000 0 1 0.3
ONLY CCOPS RECEIVE THE 1.0 CC CRD + 0.3 F/U CRD - NO CREDIT TO NCCTG (FUNDED VIA CONTRACT)
98-92-55 Intervention Study

Closed 8/16/2002 0 0.7


ACOSOG-Z0011 Breast ACOSOG-Z0011 NCCTG CL 12/15/2004 1 0 0 0
C89803(N) Gastrointestinal C89803 CALGB CL 5/15/2001 1 0 0 0
C9581(N) Gastrointestinal
CALGB CL 5/31/2002 1.1 0 0 0 0.1 CREDIT FOR MARKER STUDY
C9633(N) Lung Non-Small Cell CALGB-9633 CALGB CL 1/6/2004 1 0 0 0
C9732(N) Lung C9732 CALGB CL 7/13/2001 1 0 0 0
C9734(N) Lung Non-Small Cell C9734 CALGB CL 6/30/2000 1 0 0 0
C9741(N) Breast C9741 CALGB CL 3/31/1999 1 0 0 0
C9781(N) Other C9781 CALGB CL 3/31/2002 1 0 0 0
E1199 Breast E1199 ECOG CL 1/15/2002 1
0 0
E1C99 Other E1C99 ECOG CL 1/18/2008 1
0 0
E1Z96(N) Other E1Z96 ECOG CL 1/14/2000 0 1 0 0
E2196 Breast E2196 ECOG CL 6/13/2001 1
0 0
E2197(N) Breast E2197 ECOG CL 1/21/2000 1 0 0 0
E2399 Head and Neck E2399 ECOG CL 3/31/2001 1
0 0
E5194(N) Breast E5194 ECOG CL 10/22/2002 1.1 0 0 0
E5597 Intervention Study E5597
Active

1 0.3

I89-0001 Pilot Study I89-0001
Closed 2/8/1994 0 1

LOCAL: NCCTG-89-51-51
JC010 Gastrointestinal
NCIC AC
1 0.5 0 0 0.5 CREDIT FOR QOL COMPONENT
MA.17 Breast MA.17 NCIC CL 5/31/2002 1 0.5 0 0 0.5 CC CREDIT FOR QOL
MC9944 Intervention Study

Closed 8/15/2005
1

Cancer Control credit increased from 0.8 to 1.0 as of June 1, 2003
N0021 Other
NCCTG CL 5/3/2002 1
0 0
N0022 Lung Non-Small Cell
NCCTG CL 3/8/2002 1 0.5 0 0 CC Credit is for QOL
N0026 Lung Non-Small Cell
NCCTG CL 5/23/2003 1
0 0
N0027 Lung
NCCTG CL 1/7/2003 1
0 0
N0028 Lung Non-Small Cell
NCCTG AC
1
0 0
N0031 Breast
NCCTG CL 12/31/2001 1 0 0 0
N0032 Breast
NCCTG CL 4/23/2004 1
0 0
N0037 Breast
NCCTG CL 5/25/2007 0.1 0 0 0
N003A Breast
NCCTG CL 3/7/2003 1
0 0
N0041 Hepatic
NCCTG CL 11/18/2003 1
0 0
N0042 Hepatic
NCCTG CL 9/6/2002 1
0 0
N0043 Other
NCCTG CL 11/30/2001 1
0 0
N0044 Gastrointestinal
NCCTG CL 1/7/2005 1 0 0 0 No DCP Review of QOL
N0048 Gastrointestinal
NCCTG CL 3/14/2003 1
0 0 NO CC Credit for QOL
N004E Other
NCCTG CL 8/31/2007 1 0 0 0
N0052 Genitourinary
NCCTG CL 10/31/2003 1 0.5 0 0 0.5 cc credit for QOL
N0071 Melanoma
NCCTG CL 8/3/2007 1 0 0 0
N0074 Brain
NCCTG CL 8/2/2002 1
0 0
N0087 Lymphomas
NCCTG CL 10/8/2004 1
0 0
N0093 Other
NCCTG CL 11/24/2006 0.1 0 0 0
N00C1 Intervention Study

Closed 3/1/2005
1 0
Cancer Control credit increased from 0.8 to 1.0 as of June 1, 2003
N00C3 Intervention Study

Closed 12/5/2003
1 0
Cancer Control credit increased from 0.7 to 1.0 as of June 1, 2003
N00C9 Intervention Study

Closed 10/27/2006
1 0
Cancer Control Credit increased from 0.7 to 1.0 as of June 1, 2002.
N00CA Intervention Study

Closed 10/28/2005
1

Cancer Control credit increased from 0.7 to 1.0 as of June 1, 2003
N00CB Intervention Study

Closed 11/10/2006
1

Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003
N0124 Lung N0124 NCCTG CL 7/2/2004 1
0 0
N0147 Gastrointestinal N0147 NCCTG AC
1 0.5 0 0 0.5 Cancer Control credit for QOL
N0149 Gastrointestinal
NCCTG CL 5/7/2004 1
0 0
N014A Gastrointestinal
NCCTG CL 10/26/2007 1 0.5 0 0 0.5 Cancer Control credit for QOL
N014C Other
NCCTG CL 11/21/2003 1 0.3 0 0 0.3 Cancer Control credit for QOL component
N0177 Brain
NCCTG AC
1
0 0
N0186 Lymphomas Non-Hodgkin's
NCCTG CL 9/2/2005 1
0 0
N0189 Lymphomas
NCCTG CL 9/23/2005 1
0 0
N01C3 Intervention Study

Closed 6/13/2005 0 1

Cancer Control credit increased from 0.7 to 1.0 as of June 1, 2003
N01C4 Intervention Study

Closed 10/7/2005 0 1 0
Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003
N01C5 Intervention Study

Closed 10/9/2007 0 1 0
Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003
N01C8 Intervention Study

Closed 7/15/2005 0 1 0
Cancer Control credit increased from 0.8 to 1.0 as of June 1, 2003
N01C9 Intervention Study

Closed 10/5/2005
1 0
Cancer Control credit increased from 0.8 to 1.0 as of June 1, 2003
N01CB Intervention Study

Closed 7/27/2006
1 0
Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003
N01CC Intervention Study

Closed 3/5/2004 0 1 0
Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003
N0222 Lung Non-Small Cell
NCCTG CL 2/24/2006 1 0.5 0 0 0.5 Cancer Control credit for QOL
N0234 Breast
NCCTG CL 7/8/2004 1 0 0 0
N0242 Gastric
NCCTG CL 4/8/2005 1 0 0 0
N0272 Brain
NCCTG AC
1 0 0 0
N0274 Melanoma
NCCTG CL 9/9/2005 1 0 0 0
N0275 Melanoma
NCCTG AC
1 0 0 0
N027D Brain
NCCTG AC
1 0 0 0
N02C1


Closed 3/3/2006 0 1

Cancer Control credit increased from 0.7 to 1.0 as of June 1, 2003
N02C2 Intervention Study

Closed 3/26/2004
1 0
Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003
N02C3 Intervention Study

Closed 4/23/2004 0 1 0

N02C4 Intervention Study

Closed 11/13/2007 0 1


N0321 Lung Non-Small Cell
NCCTG AC
1 0 0 0
N0322 Lung
NCCTG CL 8/24/2005 1 0.3 0 0 0.3 Cancer Control credit for QOL
N0323 Lung Non-Small Cell
NCCTG CL 11/3/2006 1 0 0 0
N0326 Lung Non-Small Cell
NCCTG CL 8/4/2006 1 0 0 0
N0332 Breast
NCCTG CL 11/6/2006 1 0 0 0
N0336 Breast
NCCTG CL 5/16/2007 1 0 0 0
N0337 Breast
NCCTG AC
1 0 0 0
N0338 Breast
NCCTG CL 7/6/2007 1 0 0 0
N0341 Other
NCCTG CL 4/8/2005 1
0 0
N0342 Gastrointestinal
NCCTG CL 8/4/2006 1 0.5 0 0 Cancer control credit for QOL
N0346 Other
NCCTG CL 12/9/2005 1 0.5 0 0 Cancer control for QOL
N0349 Gastrointestinal
NCCTG CL 5/5/2006 1 0 0 0 Previously 0.3 CC credit assigned in error for QOL. There is no QOL component thus the deletion of the CC credit.
N034A Gastrointestinal
NCCTG CL 5/19/2006 1 0 0 0
N0351 Genitourinary
NCCTG CL 12/23/2004 1
0 0
N0377 Melanoma
NCCTG CL 3/2/2007 1 0 0 0
N038H Lymphomas
NCCTG AC
1 0 0 0
N03C5 Intervention Study

Closed 7/29/2005 0 1 0

N03CA Intervention Study

Closed 7/5/2006 0 1 0

N03CB Intervention Study

Active
0 1 0

N03CC Intervention Study

Closed 3/31/2006 0 1 0 0
N0422 Lung Non-Small Cell
NCCTG AC
1 0 0 0
N0423 Lung
NCCTG AC
1 0 0 0
N0426 Lung Non-Small Cell N0426 NCCTG CL 2/23/2007 1 0 0 0
N0432 Breast
NCCTG CL 9/16/2005 1 0 0 0
N0436 Breast
NCCTG CL 1/19/2007 1 0 0 0
N0437 Breast
NCCTG CL 4/20/2007 1 0 0 0
N044B Gastric
NCCTG AC
1 0 0 0
N044E Head and Neck
NCCTG CL 11/9/2007 1 0 0 0
N044J Hepatic
NCCTG CL 8/31/2007 1 0 0 0
N047A Melanoma
NCCTG CL 11/3/2006 1 0 0 0
N047B Brain
NCCTG AC
1 0 0 0
N0489 Lymphomas
NCCTG CL 8/14/2007 1 0 0 0
N048F Leukemia, Chronic
NCCTG AC
1 0 0 0
N04C2 Intervention Study

Active
0 1 0

N04C7 Intervention Study

Closed 6/19/2007 0 1 0

N04CA Intervention Study

Active
0 1 0